DA
ELV icon

Drake & Associates’s Elevance Health ELV Stock Holding History

Drake & Associates’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-576
Closed -$278K – 66
2022
Q2 		$278K Buy
+576
New +$285K 0.16% 40

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Drake & Associates's ELV Position: Q3 2022 in Review

Drake & Associates sold out of Elevance Health (ELV) in Q3 2022, closing a stake of 576 shares — an estimated $278K sold.

Drake & Associates first reported a position in ELV in Q2 2022 and held it in 1 quarter. The position peaked at $278K in Q2 2022. 1,446 funds tracked by Wall St. Rank hold ELV as of Q3 2022.

  • Drake & Associates reported no remaining Elevance Health position as of Q3 2022 after selling out during the quarter.
  • Drake & Associates sold 576 Elevance Health shares in Q3 2022, an estimated $278K.
  • Drake & Associates first reported a position in Elevance Health in Q2 2022 and held it in 1 quarter.
  • Drake & Associates's Elevance Health position peaked at $278K in Q2 2022.
  • 1,446 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.

Based on Drake & Associates's 13F filing for Q3 2022, filed 17 Oct 2022.